| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Tak Paul Peter is a Chief Executive Officer at Candel Therapeutics, Inc.. Recent SEC Form 4 filings include 3 buys and 7 sells.
Estimated insider holdings value: $2.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2025 | CADL Candel Therapeutics, Inc. | Chief Executive Officer | Sell | 26,172 | $8.77 | $229,624.02 | -5.5% | -44.5% | -44.8% | |
| Jan 15, 2025 | CADL Candel Therapeutics, Inc. | Chief Executive Officer | Sell | 21,704 | $7.23 | $156,811.40 | -7.9% | -38.1% | -25.7% | |
| Jan 8, 2025 | CADL Candel Therapeutics, Inc. | Chief Executive Officer | Sell | 21,172 | $8.22 | $173,995.73 | -7.2% | -49.7% | -36.4% | |
| Nov 29, 2024 | CADL Candel Therapeutics, Inc. | Chief Executive Officer | Sell | 48,847 | $4.56 | $222,527.39 | -14.2% | +82.8% | +1.4% | |
| Jul 17, 2024 | CADL Candel Therapeutics, Inc. | Chief Executive Officer | Sell | 22,528 | $6.47 | $145,814.73 | -6.4% | -9.4% | +5.3% | |
| Jul 11, 2024 | CADL Candel Therapeutics, Inc. | Chief Executive Officer | Sell | 20,293 | $5.97 | $121,218.21 | -5.4% | +1.4% | -1.7% | |
| Dec 9, 2022 | CADL Candel Therapeutics, Inc. | Chief Executive Officer | Buy | 15,985 | $1.88 | $30,020.20 | +30.1% | -16.3% | -56.9% | |
| Jul 29, 2021 | CADL Candel Therapeutics, Inc. | Chief Executive Officer | Buy | 25,000 | $8.00 | $200,000.00 | New | +57.5% | -57.5% |